EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Editas Medicine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$2.42+0.07 (+2.98%)
Close on Oct 19, 2026
- Market cap
- $288.69M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Editas Medicine has not reported a dividend
No dividend per share appears in Editas Medicine's annual filings since fiscal 2013.